StockWatch
·
Biotechnology: Pharmaceutical Preparations
Quarterly ResultApr 27, 2026, 08:24 AM

APLM Reports Full Year 2025 Results, Clinical & Business Updates

AI Summary

Apollomics Inc. announced its full-year 2025 financial results, along with updates on its clinical programs and overall business progress. This information was released via a press release on April 27, 2026, which was subsequently furnished as Exhibit 99.1 to a Form 6-K filing with the SEC.

Key Highlights

  • Apollomics Inc. reported full year 2025 financial results.
  • The company provided updates on its clinical programs.
  • The company highlighted business progress.
  • The announcement was made via a press release on April 27, 2026.
  • The press release was furnished as Exhibit 99.1 to the Form 6-K.